Medical robotics

ASTM International Selects Humotech and Exoskeleton Report to Lead New Exo Technology Center of Excellence

Retrieved on: 
Tuesday, October 29, 2019
Technology, Musical groups, Musicians, Medical robotics, Body armor, Powered exoskeleton, Exo, ASTM International

W. CONSHOHOCKEN, Pa., Oct. 29, 2019 /PRNewswire/ --ASTM International, a global leader in standards and related services, announced today the winners of a worldwide competition to lead its new Exo Technology Center of Excellence.

Key Points: 
  • W. CONSHOHOCKEN, Pa., Oct. 29, 2019 /PRNewswire/ --ASTM International, a global leader in standards and related services, announced today the winners of a worldwide competition to lead its new Exo Technology Center of Excellence.
  • The center will support standards-focused research and related activities that help accelerate innovation in the emerging exoskeletons and exosuits industry.
  • From a diverse pool of submitted proposals, Humotech and the Exoskeleton Report were co-selected.
  • Morgan also announced that ASTM International has hired Bill Billotte, Ph.D., formerly a physical scientist with the U.S. National Institute of Standards and Technology, to serve as director of global exo technology programs.

The global medical exoskeleton market is expected to reach US$ 1,023.0 Mn in 2027 from US$ 96.7 Mn in 2018

Retrieved on: 
Tuesday, October 29, 2019
Articles, Prosthetics, Medical robotics, Health, Medicine, Powered exoskeleton, Cerebral palsy, Skeleton, Sclerosis

NEW YORK, Oct. 29, 2019 /PRNewswire/ -- The global medical exoskeleton market is expected to reach US$ 1,023.0 Mn in 2027 from US$ 96.7 Mn in 2018.

Key Points: 
  • NEW YORK, Oct. 29, 2019 /PRNewswire/ -- The global medical exoskeleton market is expected to reach US$ 1,023.0 Mn in 2027 from US$ 96.7 Mn in 2018.
  • The Medical Exoskeleton market is estimated to grow with a CAGR of 29.4% from 2019-2027.
  • The market is driven by the factors such as, increase in the number of orthopaedic surgeries, rise in the geriatric population and growing incidences of road accidents.
  • Based on the type the medical exoskeleton market is segmented into powered exoskeleton, passive exoskeleton); extremity (lower body exoskeleton, upper body exoskeleton.Based on the application the market was segmented into spinal cord injury, multiple sclerosis, cerebral palsy, stroke and others.

Ekso Bionics® to Report Third Quarter 2019 Financial Results on October 30, 2019

Retrieved on: 
Wednesday, October 23, 2019
Ekso Bionics, Articles, Assistive technology, Life sciences, Bionics, Medical robotics, Powered exoskeleton

RICHMOND, Calif., Oct. 23, 2019 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the third quarter 2019 after the close of trading on Wednesday, October 30, 2019.

Key Points: 
  • RICHMOND, Calif., Oct. 23, 2019 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the third quarter 2019 after the close of trading on Wednesday, October 30, 2019.
  • ET to discuss the financial results and recent business developments.
  • Ekso Bionics is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance, and mobility across medical and industrial applications.
  • The Company is headquartered in the Bay Area and is listed on the Nasdaq Capital Market under the symbol EKSO.

Ekso Bionics to Present at the Cantor Fitzgerald Global Healthcare Conference on October 3, 2019

Retrieved on: 
Monday, September 23, 2019
Ekso Bionics, Articles, Technology, Assistive technology, Medical robotics, Powered exoskeleton

RICHMOND, Calif., Sept. 23, 2019 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), a leading developer of exoskeletons for medical and industrial use, today announced that Jack Peurach, President and Chief Executive Officer of Ekso Bionics, will present at the Cantor Fitzgerald Global Healthcare Conference in New York City at 8:20 am ET on Thursday, October 3, 2019.

Key Points: 
  • RICHMOND, Calif., Sept. 23, 2019 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), a leading developer of exoskeletons for medical and industrial use, today announced that Jack Peurach, President and Chief Executive Officer of Ekso Bionics, will present at the Cantor Fitzgerald Global Healthcare Conference in New York City at 8:20 am ET on Thursday, October 3, 2019.
  • Ekso Bionicsis a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance and mobility across medical and industrial applications.
  • Ekso Bionics is the only exoskeleton company to offer technologies that range from helping those with paralysis to stand up and walk, to enhancing human capabilities on job sites across the globe.
  • The Company is headquartered in the San Francisco Bay Area and is listed on the Nasdaq Capital Market under the symbol EKSO.

Assistive Robotics (Physically, Socially, Mixed Assistive) Market - Global Forecast to 2024 - ResearchAndMarkets.com

Retrieved on: 
Friday, August 30, 2019
Technology, Other Technology, Robot, Science in popular culture, Assistive technology, Medical robotics, Culture

The "Assistive Robotics Market by Mobility, Type (Physically, Socially, Mixed Assistive), Application (Elderly Assistance, Companionship, Handicap Assistance, Surgery Assistance, Industrial, Defense, Public Relations), and Geography - Global Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Assistive Robotics Market by Mobility, Type (Physically, Socially, Mixed Assistive), Application (Elderly Assistance, Companionship, Handicap Assistance, Surgery Assistance, Industrial, Defense, Public Relations), and Geography - Global Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.
  • The Assistive Robotics Market is Expected to Grow from USD 4.1 Billion in 2019 to USD 11.2 Billion by 2024, at a CAGR of 22.3%
    One of the major driving factors for the assistive robotics market is the rising insurance coverage for medical exoskeletons and robotic surgeries.
  • Hence, increasing prevalence of strokes and spinal cord injuries is another key factor driving the growth of the assistive robotics market.
  • The market for physically assistive robots is expected to grow at the highest CAGR during the forecast period.

Ekso Bionics® Unveils the Next Generation Exoskeleton for Neurorehabilitation

Retrieved on: 
Thursday, August 15, 2019
Robotics, Medical robotics, Articles, Assistive technology, Ekso Bionics, Prosthetics, Powered exoskeleton, NeuroRehabilitation, Exoskeleton, Berkeley Robotics and Human Engineering Laboratory, Proportional myoelectric control

RICHMOND, Calif., Aug. 15, 2019 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ: EKSO), a leading developer of exoskeletons for medical and industrial use, today unveiled EksoNR, the next generation EksoGT the most clinically used robotic exoskeleton.

Key Points: 
  • RICHMOND, Calif., Aug. 15, 2019 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ: EKSO), a leading developer of exoskeletons for medical and industrial use, today unveiled EksoNR, the next generation EksoGT the most clinically used robotic exoskeleton.
  • Developed for neurorehabilitation, EksoNR is an intuitive exoskeleton device that empowers patients recovering from stroke or other conditions to learn to walk again with a more natural gait.
  • Ekso Bionics is committed to developing the latest exoskeleton advances for rehabilitation.
  • Ekso Bionics is the only exoskeleton company to offer technologies that range from helping those with paralysis to stand up and walk, to enhancing human capabilities on job sites across the globe.

Assistive Robotics Market Worth $11.2 Billion by 2024 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Friday, August 16, 2019
Robot, Science in popular culture, Assistive technology, Medical robotics

CHICAGO, Aug. 16, 2019 /PRNewswire/ -- According to the new market research report "Assistive Robotics Market by Mobility, Type (Physically, Socially, Mixed Assistive), Application (Elderly Assistance, Companionship, Handicap Assistance, Surgery Assistance, Industrial, Defense, Public Relations), and Geography - Global Forecast to 2024", published by MarketsandMarkets, the Assistive Robotics Market is expected to grow from USD 4.1 billion in 2019 to USD 11.2 billion by 2024, at a CAGR of 22.3% during the forecast period.

Key Points: 
  • CHICAGO, Aug. 16, 2019 /PRNewswire/ -- According to the new market research report "Assistive Robotics Market by Mobility, Type (Physically, Socially, Mixed Assistive), Application (Elderly Assistance, Companionship, Handicap Assistance, Surgery Assistance, Industrial, Defense, Public Relations), and Geography - Global Forecast to 2024", published by MarketsandMarkets, the Assistive Robotics Market is expected to grow from USD 4.1 billion in 2019 to USD 11.2 billion by 2024, at a CAGR of 22.3% during the forecast period.
  • Hence, the increasing prevalence of strokes and spinal cord injuries is one of the key factors driving the growth of the assistive robotics market.
  • Another driver for the assistive robotics market includes rising insurance coverage for medical exoskeletons and robotic surgeries.
  • North America is expected to hold the largest share of the assistive robotics market in 2019 and is projected to dominate the market during the forecast period.

Assistive Robotics Market Worth $11.2 Billion by 2024 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Friday, August 16, 2019
Robot, Science in popular culture, Assistive technology, Medical robotics

CHICAGO, Aug. 16, 2019 /PRNewswire/ -- According to the new market research report "Assistive Robotics Market by Mobility, Type (Physically, Socially, Mixed Assistive), Application (Elderly Assistance, Companionship, Handicap Assistance, Surgery Assistance, Industrial, Defense, Public Relations), and Geography - Global Forecast to 2024", published by MarketsandMarkets, the Assistive Robotics Market is expected to grow from USD 4.1 billion in 2019 to USD 11.2 billion by 2024, at a CAGR of 22.3% during the forecast period.

Key Points: 
  • CHICAGO, Aug. 16, 2019 /PRNewswire/ -- According to the new market research report "Assistive Robotics Market by Mobility, Type (Physically, Socially, Mixed Assistive), Application (Elderly Assistance, Companionship, Handicap Assistance, Surgery Assistance, Industrial, Defense, Public Relations), and Geography - Global Forecast to 2024", published by MarketsandMarkets, the Assistive Robotics Market is expected to grow from USD 4.1 billion in 2019 to USD 11.2 billion by 2024, at a CAGR of 22.3% during the forecast period.
  • Hence, the increasing prevalence of strokes and spinal cord injuries is one of the key factors driving the growth of the assistive robotics market.
  • Another driver for the assistive robotics market includes rising insurance coverage for medical exoskeletons and robotic surgeries.
  • North America is expected to hold the largest share of the assistive robotics market in 2019 and is projected to dominate the market during the forecast period.

ReWalk Robotics to Report Second Quarter 2019 Financial Results on August 8, 2019

Retrieved on: 
Tuesday, August 6, 2019
Articles, Technology, Assistive technology, Medical robotics, ReWalk, Prosthetics, Powered exoskeleton, Robotics, Ekso Bionics

ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.

Key Points: 
  • ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.
  • ReWalks mission is to fundamentally change the quality of life for individuals with lower limb disability through the creation and development of market leading robotic technologies.
  • Founded in 2001, ReWalk has headquarters in the U.S., Israel and Germany.
  • ReWalk is a registered trademark of ReWalk Robotics Ltd. in Israel and the Unites States.

ReWalk Robotics Receives CE Mark for ReStore™ Exo-Suit Stroke Rehabilitation Device

Retrieved on: 
Wednesday, May 29, 2019
Assistive technology, Robots, Articles, ReWalk, Medical robotics, HAL, Gait training, Stroke

and YOKNEAM ILIT,Israel, May 29, 2019 /PRNewswire/ -- ReWalk Robotics, Ltd.(Nasdaq: RWLK) ("ReWalk" or the "Company"), a manufacturer of robotic medical devices for individuals with lower limb disabilities, today announced that the ReStore Exo-Suit for stroke rehabilitation has received CE marking, clearing it for sale to rehabilitation clinics in the European Union.

Key Points: 
  • and YOKNEAM ILIT,Israel, May 29, 2019 /PRNewswire/ -- ReWalk Robotics, Ltd.(Nasdaq: RWLK) ("ReWalk" or the "Company"), a manufacturer of robotic medical devices for individuals with lower limb disabilities, today announced that the ReStore Exo-Suit for stroke rehabilitation has received CE marking, clearing it for sale to rehabilitation clinics in the European Union.
  • This CE Mark is the first clearance of a soft exo-suit, a next generation medical device which can serve a larger and more diverse patient population facing mobility challenges.
  • "The ReStore revolutionizes post stroke gait training, providing key advantage to clinics, therapists and patients," said ReWalk CEO Larry Jasinski.
  • The company announced that ReStore will be priced significantly lower than the first generation of rigid exoskeleton technologies, and can be used to treat a broad range of stroke rehabilitation patients.